Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jean‐François Deleuze"'
Autor:
Xavier Pivot, Gilles Romieu, Pierre Fumoleau, Maria Rios, Hervé Bonnefoi, Thomas Bachelot, Patrick Soulié, Christelle Jouannaud, Hugues Bourgeois, Thierry Petit, Isabelle Tennevet, David Assouline, Marie-Christine Mathieu, Jean-Philippe Jacquin, Sandrine Lavau-Denes, Ariane Darut-Jouve, Jean-Marc Ferrero, Carole Tarpin, Christelle Lévy, Valérie Delecroix, Véronique Trillet-Lenoir, Oana Cojocarasu, Jérôme Meunier, Jean-Yves Pierga, Cécile Agostini, Pierre Kerbrat, Céline Faure-Mercier, Hélène Blanché, Mourad Sahbatou, Anne Boland, Delphine Bacq, Céline Besse, Fabien Calvo, Alexia Renaud, Jean-François Deleuze, Iris Pauporté, Gilles Thomas, David G. Cox
Publikováno v:
npj Breast Cancer, Vol 3, Iss 1, Pp 1-5 (2017)
Genetics: heredity does not explain HER2 expression A large gene-finding study failed to identify any hereditary factors linked to HER2 expression among women with breast cancer. A team in France led by Xavier Pivot from the University Hospital Cente
Externí odkaz:
https://doaj.org/article/7754f161934e43488fc3e34446964363
Autor:
Maria Rios, Alexia Renaud, Valérie Delecroix, Oana Cojocarasu, Céline Besse, Fabien Calvo, Mourad Sahbatou, Véronique Trillet-Lenoir, Ariane Darut-Jouve, Sandrine Lavau-Denes, Patrick Soulié, Hélène Blanché, Hervé Bonnefoi, Marie-Christine Mathieu, Céline Faure-Mercier, David G. Cox, Jean-Yves Pierga, Christelle Jouannaud, Thierry Petit, Jean-Marc Ferrero, Pierre Kerbrat, Christelle Levy, Carole Tarpin, Thomas Bachelot, Jérôme Meunier, Anne Boland, David Assouline, Gilles Romieu, Jean-François Deleuze, Cécile Agostini, Gilles Thomas, Isabelle Tennevet, Delphine Bacq, Jean-Philippe Jacquin, Iris Pauporté, Pierre Fumoleau, Xavier Pivot, Hugues Bourgeois
Publikováno v:
NPJ Breast Cancer
npj Breast Cancer, Vol 3, Iss 1, Pp 1-5 (2017)
npj Breast Cancer, Vol 3, Iss 1, Pp 1-5 (2017)
Human epidermal growth factor receptor 2-positive breast cancer is a subtype of interest regarding its outcome and the impressive impact of human epidermal growth factor receptor 2 targeted therapy. Constitutional variants may be involved in the aeti